The role of the chemokine receptor XCR1 in breast cancer cells

References

• ZhangJZhouZWangCReduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanismCancer Immunol Immunother201160455957321240488
   PubMed Web of Science ®Google Scholar
• LeiYTakahamaYXCL1 and XCR1 in the immune systemMicrobes Infect201214326226722100876
   PubMed Web of Science ®Google Scholar
• KumarSChoiWTDongCZSMM-chemokines: a class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic developmentChem Biol2006131697916426973
   PubMedGoogle Scholar
• DongCChuaAGangulyBKrenskyAMClaybergerCGlycosylated recombinant human XCL1/lymphotactin exhibits enhanced biologic activityJ Immunol Methods20053021–213614415992811
   PubMed Web of Science ®Google Scholar
• BachemAHartungEGüttlerSExpression of XCR1 characterizes the Batf3-dependent lineage of dendritic cells capable of antigen cross-presentationFront Immunol2012321422826713
   PubMed Web of Science ®Google Scholar
• YamazakiCMiyamotoRHoshinoKConservation of a chemokine system, XCR1 and its ligand, XCL1, between human and miceBiochem Biophys Res Commun2010397475676120541533
   PubMed Web of Science ®Google Scholar
• NguyenKDFohnerABookerJDDongCKrenskyAMNadeauKCXCL1 enhances regulatory activities of CD4+ CD25(high) CD127(low/−) T cells in human allergic asthmaJ Immunol200818185386539518832695
   PubMed Web of Science ®Google Scholar
• YehPTLinFALinCPYangCMChenMSYangCHExpressions of lymphotactin and its receptor, XCR, in Lewis rats with experimental autoimmune anterior uveitisGraefes Arch Clin Exp Ophthalmol2010248121737174720585797
   PubMed Web of Science ®Google Scholar
• EndresMAndreasKKalwitzGChemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cellsOsteoarthritis Cartilage201018111458146620709179
   PubMed Web of Science ®Google Scholar
• OrdwayDHigginsDMSanchez-CampilloJXCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stabilityJ Leukoc Biol20078251221122917699612
   PubMed Web of Science ®Google Scholar
• SeowSWRahmatJNBayBHLeeYKMahendranRExpression of chemokine/cytokine genes and immune cell recruitment following the instillation of mycobacterium bovis, bacillus calmetteguerin or lactobacillus rhamnosus strain GG in the healthy murine bladderImmunology2008124341942718217952
   PubMed Web of Science ®Google Scholar
• KhurramSAWhawellSABingleLMurdochCMcCabeBMFarthingPMFunctional expression of the chemokine receptor XCR1 on oral epithelial cellsJ Pathol2010221215316320225245
   PubMed Web of Science ®Google Scholar
• KimMRooperLXieJThe lymphotactin receptor is expressed in epithelial ovarian carcinoma and contributes to cell migration and proliferationMol Cancer Res201210111419142922964431
   PubMed Web of Science ®Google Scholar
• YamashitaYKajiuraDTangLXCR1 expression and biased VH gene usage are distinct features of diffuse large B-cell lymphoma initially manifesting in the bone marrowAm J Clin Pathol2011135455656421411777
   PubMed Web of Science ®Google Scholar
• LiJYOuZLYuSJThe chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancerBreast Cancer Res Treat2012131383784821479551
   PubMed Web of Science ®Google Scholar
• JonesLWVigliantiBLTashjianJAEffect of aerobic exercise on tumor physiology in an animal model of human breast cancerJ Appl Physiol2010108234334819959769
   PubMed Web of Science ®Google Scholar
• RossiDZlotnikAThe biology of chemokines and their receptorsAnnu Rev Immunol20001821724210837058
   PubMed Web of Science ®Google Scholar
• CauxCAit-YahiaSCheminKDendritic cell biology and regulation of dendritic cell trafficking by chemokinesSpringer Semin Immunopathol200022434536911155441
   PubMed Web of Science ®Google Scholar
• FacciabeneAPengXHagemannISTumour hypoxia promotes tolerance and angiogenesis via CCL28 and T (reg) cellsNature2011475735522623021753853
   PubMed Web of Science ®Google Scholar
• ZhangMXHanNYuSYLengYChemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude miceZhonghua Zhong Liu Za Zhi2008305325329 Chinese18953828
   PubMedGoogle Scholar
• SenguptaSSchiffRKatzenellenbogenBSPost-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cellsBreast Cancer Res Treat2009117224325118807177
   PubMed Web of Science ®Google Scholar
• YoshidaTImaiTKakizakiMNishimuraMTakagiSYoshieOIdentification of single C motif-1/lymphotactin receptor XCR1J Biol Chem19982732616551165549632725
   PubMed Web of Science ®Google Scholar
• RussellHVStrotherDMeiZPhase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactinJ Immunother200730222723317471169
   PubMed Web of Science ®Google Scholar
• KeenJCGarrett-MayerEPettitCEpigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cellsCancer Biol Ther20043121304131215662126
   PubMed Web of Science ®Google Scholar
• SosMLFischerSUllrichRIdentifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerProc Natl Acad Sci U S A200910643183511835619805051
   PubMed Web of Science ®Google Scholar
• MirzoevaOKDasDHeiserLMBasal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibitionCancer Res200969256557219147570
   PubMed Web of Science ®Google Scholar
• QiXZhiHLeppAp38gamma mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcriptionJ Biol Chem201228718146811469122399296
   PubMed Web of Science ®Google Scholar
• ChenJSunLFormononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptor-positive human breast cancer cellsHorm Metab Res2012441394394822828872
   PubMed Web of Science ®Google Scholar
• LiuXWangLChenJEstrogen receptor beta agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathwayMol Med Rep20151121516152225351348
   PubMed Web of Science ®Google Scholar
• DePMiskiminsKDeyNLeyland-JonesBPromise of rapalogues versus mTOR kinase inhibitors in subset specific breast cancer: old targets new hopeCancer Treat Rev201339540341223352077
   PubMed Web of Science ®Google Scholar
• SetoBRapamycin and mTOR: a serendipitous discovery and implications for breast cancerClin Transl Med2012112923369283
   PubMedGoogle Scholar
• QinLWangZTaoLWangYER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagyAutophagy20106223924720104019
   PubMed Web of Science ®Google Scholar
• RhodesLVShortSPNeelNFCytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancerCancer Res201171260361321123450
   PubMed Web of Science ®Google Scholar
• LiangZBrooksJWillardMCXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathwayBiochem Biophys Res Commun2007359371672217559806
   PubMed Web of Science ®Google Scholar
• DragowskaWHVerreaultMYappDTDecreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycinBreast Cancer Res Treat2007106331933117347776
   PubMed Web of Science ®Google Scholar
• CasaAJDearthRKLitzenburgerBCLeeAVCuiXThe type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistanceFront Biosci2008133273328718508432
   PubMed Web of Science ®Google Scholar
• MaorSMayerDYardenRIEstrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1J Endocrinol2006191360561217170218
   PubMed Web of Science ®Google Scholar
• MillerTWHennessyBTGonzález-AnguloAMHyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancerJ Clin Invest201012072406241320530877
   PubMed Web of Science ®Google Scholar